Thrombotic microangiopathy: Difference between revisions

Revision as of 07:45, 15 August 2020

@@ Line 1: / Line 1: @@
+*Syndrome of [[microangiopathic hemolytic anemia]], [[thrombocytopenia]], and microvascular thrombosis leading to organ dysfunction
-* [[Thrombotic thrombocytopenia purpura]]
+*Primary
-* [[Hemolytic-uremic syndrome]]
+**[[Thrombotic thrombocytopenia purpura]]
-* [[Atypical hemolytic-uremic syndrome]]
+**[[Hemolytic-uremic syndrome]]
+**[[Atypical hemolytic-uremic syndrome]]
+**[[HELLP syndrome]]
+*Associated with coexisting condition
+**Autoimmune disease, including [[systemic lupus erythematosus]] or [[antiphospholid antibody syndrome]]
+**Drugs, including [[quinine]], [[ticlopidine]], and [[chemotherapy]] ([[mitomycin]], [[gemcitabine]], [[cyclosporine]], and [[tacrolimus]], though it may also be caused by the underlying condition)
+**[[Sepsis]]
+**[[DIC]]
+**[[Malignancy]]
+**[[HIV]]
 [[Category:Hematology]]